Chest Pain on Adderall or Vyvanse, and the Evidence on Cardiomyopathy and Heart Failure

Chest pain while taking Adderall or another ADHD stimulant is a reason to call 911 or go to an emergency department. The Adderall XR Medication Guide lists chest pain, shortness of breath and fainting as signs of heart problems and tells readers to call the prescriber or go "to the nearest hospital emergency room right away."1

The labels give no rate for chest pain. It appears in none of the adverse-reaction tables of the Adderall XR, Vyvanse and Concerta labels (Ritalin's label has none), and none of the sources cited here reports what chest pain on a stimulant usually turns out to be.1, 2, 3, 4 In 171,126 privately insured young people aged 6 to 21 without known cardiovascular risk factors, emergency or inpatient cardiac diagnoses occurred at 0.92 per 1,000,000 days of current stimulant use.5

What the Adderall, Vyvanse and Ritalin labels say about chest pain

The labels tell prescribers to instruct patients to make immediate contact if they develop "exertional chest pain, unexplained syncope, or other symptoms suggestive of cardiac disease". Syncope is fainting.1, 2, 3, 4

Elsewhere in the labels, chest pain appears without a rate. The Vyvanse label names it among less frequent reasons children stopped the drug in a pediatric trial, the Vyvanse and Concerta labels list it among postmarketing reports, and the Concerta and Ritalin labels list angina pectoris among reported cardiac reactions, without frequencies.2, 3, 4 The Vyvanse label explains that such reactions "are reported voluntarily from a population of uncertain size," so their frequency and their causal link to the drug can't be reliably established.2

Shortness of breath does appear in a trial table: 2% of adults on Vyvanse reported dyspnea, compared with 0% on placebo.2

Emergency heart diagnoses were rare in a large youth cohort

Olfson and colleagues reviewed insurance claims of privately insured young people without known cardiovascular risk factors. Emergency or inpatient diagnoses of angina, cardiac dysrhythmia or transient cerebral ischemia had an adjusted odds ratio of 0.69 (95% CI, 0.42 to 1.12) during current stimulant use compared with no use. The authors concluded that these diagnoses "were rare and not associated with stimulant use."5

That study excluded young people with a chest pain claim before follow-up, and chest pain itself wasn't an outcome.5 A Florida Medicaid study of children and adolescents found stimulant use associated with a 20% higher hazard of emergency visits for cardiac causes or symptoms (adjusted hazard ratio 1.20; 95% CI, 1.04 to 1.38).6

Heart attacks on prescribed stimulants appear as case reports

PubMed searches run for this page in November 2026 found 6 published case reports of heart attack or an acute coronary presentation in people taking an ADHD stimulant: 4 with amphetamine salts, 1 with methylphenidate and 1 with lisdexamfetamine. A search for a systematic review of such reports found none. Case reports carry no denominator, so they can't show how often an event happens.

Two involved alcohol taken with Adderall, in a young man and in an adolescent without cardiovascular risk factors who took the full prescribed daily dose at once.7, 8 The authors of the second report called a heart attack from prescribed Adderall, without intent to overdose, "extremely rare".8

A 21-year-old man developed chest pain and ST elevations after at least 3 days on methylphenidate, and angiography showed coronary artery spasm. The authors' causality score fell in the possible range.9 A 52-year-old man on lisdexamfetamine had chest pain and ECG changes, his coronary arteries showed no obstruction, and the changes resolved on their own.10

One case presented without chest pain. A 31-year-old man on short-acting mixed amphetamine salts had palpitations, shortness of breath and lightheadedness.11 I've covered the large studies of heart attack risk in can Adderall cause a heart attack or stroke.

Can Adderall cause cardiomyopathy or heart failure?

The Adderall XR label notes "isolated reports of cardiomyopathy associated with chronic amphetamine use", and the Vyvanse label lists cardiomyopathy among postmarketing reports. The Concerta and Ritalin labels mention it in the warning about patients who already have it.1, 2, 3, 4 The Adderall XR label advises avoiding use in patients with known cardiomyopathy or other serious cardiac disease.1

Population studies disagree. In Danish adults taking ADHD medication, those taking at least one defined daily dose per day a year after starting had a 10-year heart failure risk of 1.2%, compared with 0.7% in prior users who had stopped, a risk ratio of 1.7 (95% CI, 1.3 to 2.2).12 A Swedish study of long-term use found no statistically significant increase in heart failure, which I've covered in a separate breakdown.13

A study in the Sentinel database of 2,012,948 people starting ADHD medication found heart failure or cardiomyopathy rates below 50 per 10,000 person-years in those younger than 22 and those aged 22 to 44. Rates were not higher over 3 years of use than with shorter treatment. This descriptive study reports no comparison with untreated people.14

A one-page 2024 conference abstract in the Journal of the American College of Cardiology is titled "ADHD stimulant use associated with increased risk of cardiomyopathy in young adults." Its public record has no abstract text, and no full paper turned up in this page's November 2026 search.15 In the WHO database of spontaneous reports, 13,344 of 146,489 reports on ADHD medications involved cardiovascular disease, and cardiomyopathy was reported disproportionately for all drugs studied. These reporting patterns have no denominator.16

The same November 2026 searches found 7 case publications of cardiomyopathy or acute heart failure linked to an ADHD stimulant, again a count from those searches. Two followed an overdose or an ingestion in the setting of abuse, including a 19-year-old who swallowed 30 Adderall tablets, and two described addiction or sustained amphetamine use.17, 20, 21, 22 The other three include an 18-year-old on methylphenidate with a body mass index of 40 who was also taking quetiapine, and a 17-year-old who developed chest pain and acute left ventricular dysfunction after a single dose.18, 19

Limitations of the evidence

This evidence has limitations. First, the labels give no rate for chest pain, and the serious causes appear in case reports, several involving alcohol, overdose or misuse. Second, the heart failure data come from observational studies with different countries, designs and comparison groups, and they disagree. Nevertheless, the large youth cohort found emergency cardiac diagnoses rare, and the Sentinel study found heart failure and cardiomyopathy rates no higher with longer use.

Chest pain on a stimulant goes to an emergency department first. Whether to continue the medication afterward is decided with the prescriber, and known cardiomyopathy is among the conditions in which the Adderall XR label advises avoiding use.

Frequently asked questions

Why does my chest hurt on Adderall?

None of the sources cited here reports what chest pain on a stimulant usually turns out to be, and the labels give no rate for it. The Adderall XR Medication Guide treats chest pain as a sign of a heart problem and tells readers to call the prescriber or go to the nearest hospital emergency room right away.1

Can Vyvanse cause chest pain?

The Vyvanse label lists chest pain among postmarketing reports and states that such voluntary reports can't reliably establish frequency or a causal link. Its trial section names chest pain only among less frequent reasons children stopped the drug in one trial, without a rate. Chest pain on Vyvanse calls for 911 or an emergency department.2

Can Concerta or Ritalin cause chest pain?

The Concerta label lists chest pain among postmarketing reports, and the Concerta and Ritalin labels list angina pectoris without frequencies. In one case report, a 21-year-old who developed chest pain after at least 3 days on methylphenidate had coronary artery spasm, and the authors rated the link as possible. Chest pain on either drug calls for 911 or an emergency department.3, 4, 9

Can Adderall cause cardiomyopathy?

The Adderall XR label notes isolated reports of cardiomyopathy with chronic amphetamine use. Of 7 case publications linked to ADHD stimulants in this page's November 2026 searches, 4 involved overdose, abuse, addiction or sustained amphetamine use, and a Sentinel database study of 2,012,948 people found heart failure or cardiomyopathy rates no higher over 3 years of use than with shorter treatment.1, 14

Can Adderall cause heart failure?

In Danish adults taking ADHD medication, analyzed as a group, the 10-year heart failure risk was 1.2% in those taking at least one defined daily dose per day and 0.7% in prior users, a risk ratio of 1.7. A Swedish study found no statistically significant increase. Both are observational and can't establish cause.12, 13

Chest pain, fainting, or shortness of breath during treatment needs immediate medical assessment. Call 911 or go to the nearest emergency department for severe symptoms. Medication changes are made with the prescriber.

Sources

  1. ADDERALL XR (mixed amphetamine salts). US Prescribing Information and Medication Guide. DailyMed, version 38, effective April 30, 2026.
  2. VYVANSE (lisdexamfetamine dimesylate). US Prescribing Information. DailyMed, version 81, effective April 30, 2026.
  3. CONCERTA (methylphenidate HCl) extended-release tablets. US Prescribing Information. DailyMed, version 30, effective April 20, 2026.
  4. RITALIN (methylphenidate HCl) tablets. US Prescribing Information. DailyMed, version 3, effective February 5, 2025.
  5. Olfson M, Huang C, Gerhard T, et al. Stimulants and cardiovascular events in youth with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2012;51(2):147-156.
  6. Winterstein AG, Gerhard T, Shuster J, et al. Cardiac safety of central nervous system stimulants in children and adolescents with attention-deficit/hyperactivity disorder. Pediatrics. 2007;120(6):e1494-e1501.
  7. Jiao X, Velez S, Ringstad J, Eyma V, Miller D, Bleiberg M. Myocardial infarction associated with adderall XR and alcohol use in a young man. J Am Board Fam Med. 2009;22(2):197-201.
  8. Sharma J, de Castro C, Chatterjee P, Pinto R. Acute myocardial infarction induced by concurrent use of adderall and alcohol in an adolescent. Pediatr Emerg Care. 2013;29(1):84-88.
  9. Baumeister TB, Wickenbrock I, Perings CA. STEMI secondary to coronary vasospasm: possible adverse event of methylphenidate in a 21-year-old man with ADHD. Drug Saf Case Rep. 2016;3(1):10.
  10. Perinkulam Sathyanarayanan S, Hamza Saad Shaukat M, Wilson J, Petrasko M. Myocardial infarction with nonobstructive coronary arteries (MINOCA) in a patient taking lisdexamfetamine. S D Med. 2022;75(5):210-211.
  11. Sinha A, Lewis O, Kumar R, Yeruva SL, Curry BH. Adult ADHD medications and their cardiovascular implications. Case Rep Cardiol. 2016;2016:2343691.
  12. Holt A, Strange JE, Rasmussen PV, et al. Long-term cardiovascular risk associated with treatment of attention-deficit/hyperactivity disorder in adults. J Am Coll Cardiol. 2024;83(19):1870-1882.
  13. Zhang L, Li L, Andell P, et al. Attention-deficit/hyperactivity disorder medications and long-term risk of cardiovascular diseases. JAMA Psychiatry. 2024;81(2):178-187.
  14. Mosholder AD, Taylor L, Mannheim G, Ortendahl L, Woodworth TS, Toh S. Incidence of heart failure and cardiomyopathy following initiation of medications for attention-deficit/hyperactivity disorder: a descriptive study. J Clin Psychopharmacol. 2018;38(5):505-508.
  15. Gerard P, Hale E, Kennis M, Hale Z. ADHD stimulant use associated with increased risk of cardiomyopathy in young adults [conference abstract]. J Am Coll Cardiol. 2024;83(13):666.
  16. Cho H, Lee K, Jeong YD, et al. Global burden of ADHD medication-associated cardiovascular disease, 1967-2023: a comparative analysis using the WHO pharmacovigilance database. Asian J Psychiatr. 2024;101:104209.
  17. Alsidawi S, Muth J, Wilkin J. Adderall induced inverted-Takotsubo cardiomyopathy. Catheter Cardiovasc Interv. 2011;78(6):910-913.
  18. Nymark TB, Hovland A, Bjørnstad H, Nielsen EW. A young man with acute dilated cardiomyopathy associated with methylphenidate. Vasc Health Risk Manag. 2008;4(2):477-479.
  19. Dadfarmay S, Dixon J. A case of acute cardiomyopathy and pericarditis associated with methylphenidate. Cardiovasc Toxicol. 2009;9(1):49-52.
  20. Toce MS, Farias M, Bruccoleri R, Brown DW, Burns MM. A case report of reversible Takotsubo cardiomyopathy after amphetamine/dextroamphetamine ingestion in a 15-year-old adolescent girl. J Pediatr. 2017;182:385-388.e3.
  21. Al-Juhani A, Alyaseen EM, Aseri S, Alghamdi OM. Amphetamine-dextroamphetamine-induced cardiomyopathy: a case report on heart failure in a young addict. Cureus. 2024;16(10):e71044.
  22. Chapman L, Khalifa I, Sheriff N, Colwell N. Amphetamine-induced cardiomyopathy complicated by embolic stroke: a case report. Eur Heart J Case Rep. 2022;6(2):ytac044.